Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3473896 | 1.00 | TSHR (0.47) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL3475509 | 1.00 | TSHR (0.47) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| Ammonia Solution, Strong SCHEMBL5352408 | 0.99 | TSHR (0.46) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL3474614 | 0.89 | TSHR (0.39) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL14706863 | 0.87 | TSHR (0.45) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL15850409 | 0.87 | TSHR (0.45) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL27804388 | 0.86 | TSHR (0.33) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL5352414 | 0.86 | ALDH1A1 (0.34) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL27782762 | 0.86 | TSHR (0.33) | TSHRKMT2AEPHX2ALDH1A1ESR1 | |
| SCHEMBL19519066 | 0.85 | TSHR (0.47) | TSHREPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0389420-B1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | claimed |
| US-5047489-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | claimed |
| US-4983737-A | LIGHT STABILIZERS FOR POLYMERIC SUBSTRATES | CIBA-GEIGY CORPORATION (US) | 1991-01-08 | — | — | US | claimed |
| EP-0389420-A1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | claimed |
| EP-2492081-B1 | METHOD FOR PRODUCING CURVED MEMBER HAVING HIGH QUALITY DESIGN SURFACE | TEIJIN CHEMICALS LTD (JP) | 2018-01-10 | — | — | EP | disclosed |
| EP-2716666-B1 | CURING COMPOSITION AND POLYMER | MITSUBISHI CHEM CORP (JP) | 2017-11-15 | — | — | EP | disclosed |
| US-20170198076-A1 | CURABLE COMPOSITION AND POLYMER | MITSUBISHI RAYON CO., LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| US-9663603-B2 | Curable composition and polymer | MITSUBISHI RAYON CO., LTD. (JP) | 2017-05-30 | — | — | US | disclosed |
| EP-1995056-B1 | MULTILAYER BODY | TEIJIN CHEMICALS LTD (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-9296143-B2 | Process of manufacturing a curved member having a high-grade design surface and member manufactured by the process | TEIJIN CHEMICALS, LTD. (JP) | 2016-03-29 | — | — | US | disclosed |
| US-8912287-B2 | Method for producing polymer using monomer having piperidine skeleton, and molded body | MITSUBISHI RAYON CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8859099-B2 | Laminate of an acrylic resin composition layer containing triazine based ultra-violet compounds and an organosiloxane resin composition layer | TEIJIN CHEMICALS, LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-6365652-B2 | AMIDO OR CARBAMATE SUBSTITUTED TRISARYL-1,3,5-TRIAZINES USED AS ACTINIC RADIATION STABILIZER BY INCORPORATING THE ABOVE COMPOUND INTO THE ORGANIC POLYMER BY CHEMICAL BONDING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-02 | — | — | US | disclosed |
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | GUPTA RAM BABOO (US) | 2001-11-01 | — | — | US | disclosed |
| US-6265576-B1 | STABILIZERS | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-24 | — | — | US | disclosed |
| EP-0389420-B1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5077340-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-12-31 | — | — | US | disclosed |
| US-5047489-A | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| US-4983737-A | LIGHT STABILIZERS FOR POLYMERIC SUBSTRATES | CIBA-GEIGY CORPORATION (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0389420-A1 | Ethylenically unsaturated compounds containing 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine moieties, and polymers, copolymers and stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | CRYZ, ERCC5, TELO2 | TSHR 767/4885KMT2A 1735/4885EPHX2 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.